[
    [
        {
            "time": "",
            "orginal_text": "每周大事｜康弘药业副总裁辞职；科济药业实体瘤CAR-T疗法获欧盟PRIME资格；百济神州科创板上市获证监会批准 董监高成员变化",
            "features": {
                "keywords": [
                    "康弘药业",
                    "副总裁辞职",
                    "科济药业",
                    "实体瘤CAR-T疗法",
                    "欧盟PRIME资格",
                    "百济神州",
                    "科创板上市",
                    "证监会批准",
                    "董监高成员变化"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "每周大事｜康弘药业副总裁辞职；科济药业实体瘤CAR-T疗法获欧盟PRIME资格；百济神州科创板上市获证监会批准 董监高成员变化",
            "scores": {
                "News_content": "每周大事｜康弘药业副总裁辞职；科济药业实体瘤CAR-T疗法获欧盟PRIME资格；百济神州科创板上市获证监会批准 董监高成员变化",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]